Skip to main content
. 2013 May 16;11:123. doi: 10.1186/1479-5876-11-123

Table 1.

CTA protein expression in PTL subtypes

Patients
Histological subtype
MAGE-A1(77B mAb)
Multi-MAGE-A(57B mAb)
NY-ESO-1(D8.38 mAb)
    % of positive tumor cells Staining score Staining intensity % of positive tumor cells Staining score Staining intensity % of positive tumor cells Staining score Staining intensity
1
FL
0
0
0
90
3
2
80
3
1
2
SLL
0
0
0
0
0
0
0
0
0
3
B-LBL
0
0
0
100
3
1
0
0
0
4
DLBCL
0
0
0
0
0
0
10
2
1
5
DLBCL
0
0
0
0
0
0
0
0
0
6
DLBCL
0
0
0
0
0
0
0
0
0
7
DLBCL
100
3
2
0
0
0
0
0
0
8
DLBCL
0
0
0
0
0
0
0
0
0
9
DLBCL
0
0
0
0
0
0
0
0
0
10
DLBCL
0
0
0
0
0
0
0
0
0
11
DLBCL
80
3
2
0
0
0
0
0
0
12
DLBCL
0
0
0
0
0
0
100
3
1
13
DLBCL
10
2
1
0
0
0
0
0
0
14
DLBCL
0
0
0
100
3
2
100
3
2
15
DLBCL
0
0
0
100
3
3
100
3
2
16
DLBCL
0
0
0
100
3
2
100
3
2
17
DLBCL
0
0
0
100
3
2
0
0
0
18
DLBCL
0
0
0
100
3
1
0
0
0
19
DLBCL
0
0
0
100
3
2
100
3
3
20
DLBCL
0
0
0
70
3
1
90
3
1
21
DLBCL
0
0
0
100
3
2
100
3
2
22
DLBCL
0
0
0
100
3
3
0
0
0
23
DLBCL
0
0
0
100
3
2
100
3
1
24
DLBCL
0
0
0
90
3
1
0
0
0
25
DLBCL
0
0
0
80
3
2
0
0
0
26
DLBCL
0
0
0
0
0
0
0
0
0
27 DLBCL 0 0 0 100 3 1 0 0 0

DLBCL (Diffuse Large B-cell Lymphoma), FL (Follicular Lymphoma), SLL (Small Lymphocytic Lymphoma), B-LBL (B-Lymphoblastic Lymphoma).

Staining score (percentage of positive tumor cell): 0 (negative), 1 (<10%), 2 (10–50%), 3 (>50%).

Staining intensity: 0 (negative), 1 (weak), 2 (moderate intensity), 3 (strong intensity).

HHS Vulnerability Disclosure